Genetic Correction of Haemoglobin E in an Immortalised Haemoglobin E/Beta-Thalassaemia Cell Line Using the CRISPR/Cas9 System

Scientists reported a highly efficient genetic correction of haemoglobin E mutation in the immortalised erythroid cell line cells using the CRISPR/Cas9 system.